Salesforce’s Life Sciences Cloud signals an inflection point for drug‑development IT

Salesforce announced on Aug. 26, 2025, that more than 70 companies, including pharmaceutical and medical-device players and CROs, have selected its Life Sciences Cloud to unify clinical, commercial and patient-services data. Customers include Pfizer, Takeda, Fresenius Kabi, Boehringer Ingelheim and Penumbra. Salesforce describes the platform as an end-to-end engagement system that brings together sales, service, marketing, and clinical functions. Life Sciences Cloud also offers embedded industry-specific AI tools for clinical trial recruitment, patient support programs and HCP engagement.

https://www.rdworldonline.com/salesforces-life-sciences-cloud-signals-an-inflection-point-for-drug%E2%80%91development-it/